cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Intervention 1: Intervention group: cryotherapy as a standard treatment in addition to cream (topical pharmaceutical products) containing 5% extract of Juniperus excelsa M.Bieb adminnistrate, three t
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age 18 to 70 years the maximum The maximum duration of their involvement by leishmaniasis is 4 months Having physical health except the cutaneous leishmaniasis infection Having 4 or less of the lesion leishmaniasis lesions Did not taking any of topical and systemic anti-Leishmania treatment during last 4 weeks Cutaneous leishmaniasis is approved of by smear
Exclusion criteria
Exclusion criteria: Patients with complex forms of leishmaniasis and symptoms of mucousal leishmaniasis Having more than 4 lesions The lesions greater than 5 cm Sub-cutaneous nodules Regional adenopaty if greater than 1 cm size Patients with immunodeficiency disease The infants and children less than 18 years Women in lactation and pregnancy Patients with satellite lesions or sporotrichoid lesions Patients with facial cutaneous leishmaniasis lesions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size and area of leishmaniasis lesion. Timepoint: previous of the starting the treatment, weekly in the first month of treatment and every two weeks from second month to the end of the study. Method of measurement: Cooley and math with the square millimeters. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of the healing the lesion. Timepoint: At the end of the treatment proccess. Method of measurement: The time interval between the beginning and end of treatment in days. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Mahdi Parvizi
Shiraz University of Medical Sciences
Outcome results
None listed